elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q26768696-0F4836A2-46AE-462F-9B7A-88315C216E3D
Q26768696-0F4836A2-46AE-462F-9B7A-88315C216E3D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26768696-0F4836A2-46AE-462F-9B7A-88315C216E3D
The Different Therapeutic Choices with ARBs. Which One to Give? When? Why?
P2860
Q26768696-0F4836A2-46AE-462F-9B7A-88315C216E3D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26768696-0F4836A2-46AE-462F-9B7A-88315C216E3D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
fbfa91a513d87733bc8aa0d8147273f504227aaa
P2860
Stroke prevention with the angiotensin II type 1-receptor blocker candesartan in elderly patients with isolated systolic hypertension: the Study on Cognition and Prognosis in the Elderly (SCOPE).